The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
New England Journal of MedicinePublished 5 March 1998Open access
Raymond O. Estacio, Barrett W. Jeffers, William R. Hiatt, Stacy L. Biggerstaff, Nancy Gifford, Robert W. Schrier
Citations1,175
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In this population of patients with diabetes and hypertension, a significantly higher incidence of fatal and nonfatal myocardial infarction is found among those assigned to therapy with the calcium-channel blocker nisoldipine than among those assign to receive enalapril.
Abstract
In this population of patients with diabetes and hypertension, we found a significantly higher incidence of fatal and nonfatal myocardial infarction among those assigned to therapy with the calcium-channel blocker nisoldipine than among those assigned to receive enalapril. Since our findings are based on a secondary end point, they will require confirmation.
Keywords
Medicine
New England Journal of MedicineEffect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
5,925 Citations1992Marc A. Pfeffer, Eugene Braunwald +16 more
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
New England Journal of MedicineEffects of Enalapril on Mortality in Severe Congestive Heart Failure
5,077 Citations1987The Consensus Trial Study Group*
It is concluded that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms and a significant improvement in NYHA classification was observed in the enAlapril group.
CirculationEchocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
4,493 Citations1977R DEVEREUX, Nathaniel Reichek
The best method for LVM-E identified combined cube function geometry with a modified convention for determination of left ventricular internal dimension (LVID), posterior wall thickness (PWT), and interventricular septal thickness (IVST), which excluded the thickness of endocardial echo lines from wall thicknesses and included the thickness in LVID.
The American Journal of CardiologyEffects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
3,778 Citations1988Karl Swedberg, John Kjekshus
The addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms, and the effect seems to be due to a reduction in death from progression of heart failure.
New England Journal of MedicineEffect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
3,730 Citations1992Salim Yusuf
The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction.
OphthalmologyGrading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House Classification
1,992 Citations1991
The LancetISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
1,817 Citations1995
58,050 patients entering hospitals up to 24 h after the onset of suspected acute myocardial infarction with no clear contraindications to the study treatments were randomised in a "2 x 2 x 2 factorial" study, reassuring a bout the safety of using nitrates early in acute MI.
New England Journal of MedicineEffect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1,765 Citations1996Giuseppe Maschio, Daniele Alberti +7 more
A study to determine the effect of the angiotensin-converting–enzyme inhibitor benazepril on the progression of renal insufficiency in patients with various underlying renal diseases.
CirculationNifedipine
1,181 Citations1995Curt D. Furberg, Bruce M. Psaty +1 more
In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality, and other calcium antagonists may have similar adverse effects, in particular those of the dihydropyridine type.
The LancetGISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
1,117 Citations1994GRUPPOITALIANOPERLOSTUDIODELL
JAMAThe Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
970 Citations1995Bruce M. Psaty
The findings of this study support the current guidelines from the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure that recommend diuretics and beta-blockers as first-line agents unless contraindicated, unacceptable, or not tolerated.
The LancetRetardation of angiographic progression of coronary artery disease by nifedipine
612 Citations1990P Lichtlen, W. Rafflenbeul +4 more
In patients with mild CAD nifedipine substantially suppresses disease progression as shown by the appearance of new lesions detectable by quantitative coronary arteriography.
DiabetesNIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects
553 Citations1994Johanna Kuusisto, Leena Mykkänen +2 more
NIDDM and its metabolic control and the duration of diabetes are important predictors ofCHD in elderly subjects, particularly in women, and there was a significant increase in the risk of CHD death and all CHD events in NIDDM subjects with GHbA1c levels higher than 7.0% compared with diabetic subjects with lower GHb a1c.
DiabetologiaMortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
548 Citations1987G Panzram
Revue sur le pronostic du diabete non insulinodependant: il semble que des antecedents d'hypertension arterielle, d'Hyperlipoproteinemie et d'hyperinsulinemie soient plus fortement lies aux risques d'atherosclerose que l'hyperglycemie.
AtherosclerosisThe ratio of ankle and arm arterial pressure as an independent predictor of mortality
517 Citations1991Matthew T. McKenna, Sidney Wolfson +1 more
The results suggest that the relatively technically simple measure of the ratio of ankle to brachial blood pressures, if low, carries a very poor prognosis and should prompt investigation and treatment of atherosclerotic disease in other vascular systems.
Diabetes CareCoronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
514 Citations1992Pekka Koskinen, Matti Mänttäri +4 more
Compared with similarly dyslipidemic nondiabetic subjects, patients with NIDDM are at markedly increased risk of CHD and this elevated risk can be somewhat reduced by gemfibrozil.
New England Journal of MedicineThe Management of Chronic Heart Failure
329 Citations1996Jay N. Cohn
Treatment to prevent or delay the progression of left ventricular dysfunction may be quite different from that to treat symptoms of heart failure.
American Journal of Public HealthCause-specific mortality in a population-based study of diabetes.
319 Citations1991Scot E. Moss, Ronald Klein +1 more
Diabetic persons experience very high mortality, especially from vascular diseases, compared to the general population, and age-sex standardized mortality ratios in a geographically defined population of younger onset and older onset diabetic persons are examined.
Journal of Clinical EpidemiologyDiagnostic methods for peripheral arterial disease in the san luis valley diabetes study
194 Citations1990William R. Hiatt, Julie A. Marshall +5 more
It is concluded that vascular laboratory tests provide a useful, and objective means of determining the prevalence of PAD in a geographically-based population of diabetic and control subjects.
JAMAThe risk of myocardial infarction associated with antihypertensive drug therapies
192 Citations1995Bruce M. Psaty
Archives of Internal MedicineTrends in Pharmacologic Management of Hypertension in the United States
177 Citations1995Teri A. Manolio
It is difficult to explain the continued decline in the use of less expensive agents, such as diuretics and beta-blockers, which are the only antihypertensive agents proved to reduce stroke and coronary disease in hypertensive patients.
AngiologyAnkle/Arm Pressure Index in Asymptomatic Middle-Aged Males: An Independent Predictor of Ten-Year Coronary Heart Disease Mortality
124 Citations1995Marcel Kornitzer, M. Dramaix +3 more
A reduced ABPI is an independent risk factor for coronary and cardio vascular mortality in asymptomatic middle-aged Belgian males.
American Journal of Kidney DiseasesAngiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience
98 Citations1995Hans‐Henrik Parving, Peter Rossing +2 more
Evaluated putative progression promoters, kidney function, and prognosis during long-term treatment with angiotensin-converting enzyme inhibition in insulin-dependent diabetes mellitus patients suffering from diabetic nephropathy found a significant correlation between the rate of decline in GFR and mean arterial blood pressure and albuminuria.
Archives of Internal MedicineAngina Pectoris and the Rose Questionnaire
63 Citations1971Siegfried Heyden
White men who responded positively to the Rose questionnaire but who were judged on clinical grounds to be free of angina pectoris resembled true cases of anginas insofar as their blood pressure and cholesterol level was concerned.
Controlled Clinical TrialsBaseline characteristics of participants in the appropriate blood pressure control in diabetes trial
45 Citations1996Raymond O. Estacio, Susan Savage +2 more
This report summarizes the demographic, biochemical, and clinical characteristics of the randomized patients at the time of entry into the ABCD trial and evaluates the balance between the treatment groups within each population.
PubMedThe ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
45 Citations1993Susan Savage, Johnson Nagel N +6 more
The primary outcome measure is glomerular filtration rate as assessed by 24-hour creatinine clearance, which is expected to lend interpretable and clinically relevant findings with regards to the treatment of hypertension in type II diabetes.
HypertensionSystolic blood pressure as a predictor for cardiovascular disease in diabetes. A 5-year longitudinal study.
33 Citations1985H. U. Janka, P. Dirschedl
It is concluded that systolic blood pressure has been seriously underestimated as a predictor for macrovascular events.
Archives of Internal MedicineTrends in pharmacologic management of hypertension in the United States
26 Citations1995Teri A. Manolio
American Journal of HypertensionProtective Action of Calcium Channel Antagonists in Atherogenesis and Experimental Vascular Injury
25 Citations1989David Weinstein, J G Heider
A hypothesis is presented that lipophilic calcium channel-blockers are accumulated in cell membranes and perturb metabolic function as a result of altering local membrane structure.
Journal of Diabetes and its ComplicationsEffects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy
18 Citations1996Hans‐Henrik Parving
It can be concluded that under routine medical care ACE inhibitor lisinopril is a well tolerated, effective drug for treatment of hypertensive type II diabetic patients.
PubMedInterventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
17 Citations1992David D. Waters, Jacques Lespérance
Nifedipine had no effect on overall progression and regression but reduced the rate of appearance of new coronary lesions, and these studies constitute a potentially important new approach to the management of coronary atherosclerosis.
The Journal of Clinical PharmacologyAntianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina
10 Citations1995Stephen P. Glasser, Steven R. Ripa +5 more
Therapy with this extended‐release formulation of nisoldipine is an effective once‐daily treatment for chronic stable angina pectoris and represents one of the few dihydropyridine calcium channel antagonists that has shown efficacy when administered as monotherapy to patients with angina.
Clinical TherapeuticsNisoldipine versus isosorbide dinitrate in coronary heart disease: results of a double-masked study
4 Citations1996B Heublein, Ivo Amende +3 more
Although the anti-ischemic effect of the two treatments was comparable, nisoldipine was descriptively superior to ISDN in terms of tolerability.